Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Modified DNA Aptamer That Binds the ( R )-Isomer of a Thalidomide Derivative with High Enantioselectivity
2007
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
1999
Hydroxychloroquine for the treatment of chronic graft-versus-host disease
2000
Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation
1993
Cutaneous Graft-versus-Host Disease
1998
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Chronic graft-versus-host disease: clinical manifestation and therapy
2001
Cytogenetics in acute leukemia
2003
The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
1998
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Acute graft-vs-host disease
2001
Diagnosis and management of refractoriness to platelet transfusion
2001
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
1994
Drug-Induced Hepatotoxicity
2003 Standout
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
2004
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
1998
Response to thalidomide therapy in refractory chronic graft-versus-host disease
2000
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Transfusion Medicine — Blood Transfusion
1999 Standout
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias
2002
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
1989 StandoutNobel
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Chronic graft-versus-host disease
2003 Standout
Chronic myelogenous leukemia: A review
1996
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
Coccidioidomycosis in hematopoietic stem cell transplant recipients
2005
Extending Postgrafting Cyclosporine Decreases the Risk of Severe Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation
2006
Irradiation of platelets with UV‐B light exposes fibrinogen binding sites via an intracellular mechanism
1990
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Detection of minimal residual disease
2001
Inflammatory Bowel Disease
2002 Standout
Graft-versus-host disease
2009 Standout
PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE
1999
Circos: An information aesthetic for comparative genomics
2009 Standout
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
2000
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic Neoplasms
1989
Hematopoietic Stem-Cell Transplantation
2006 Standout
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
1994
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Bone Marrow Transplantation
1994
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
1999
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)
2007
Coccidioidomycosis in Liver Transplant Patients
1997
The biology and therapy of adult acute lymphoblastic leukemia
2003
Configuration of the TP53 Gene as an Independent Prognostic Parameter of Myelodysplastic Syndrome
2003
A review of autologous hematopoietic cell transplantation
2000 Nobel
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
2001
Cancer as an evolutionary and ecological process
2006 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Transfusion-Associated Graft-versus-Host Disease
1990
Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support
2004
Cyclosporine-Induced Hypertension After Transplantation
1994
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
The thalidomide saga
2007
Overview of Platelet Transfusion
2010
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
2001
Functional Nucleic Acid Sensors
2009 Standout
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of Graft-Versus-Host Disease: A Prospective, Randomized Trial
1997
Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet Transfusions
1997
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation
2015
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Biologic effects of leukocytes present in transfused cellular blood products
1994
Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease
1991
Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7).
1995
Role of plasma, platelets, and endothelial cells in tumor metastasis
1984 Standout
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
1990
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
1994
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study
2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older.
1986
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Cancer treatment and survivorship statistics, 2016
2016 Standout
A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants
1991
Aspergillus fumigatusand Aspergillosis
1999 Standout
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Therapy of small cell lung cancer: a perspective on two decades of clinical research.
1988
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
The biology and treatment of acute lymphoblastic leukemia in adults
1995
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
2010 StandoutNobel
Thalidomide for treatment of patients with chronic graft-versus-host disease
2000
Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation
2001
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Hodgkin's lymphoma
2003
Treatment of Chronic Graft-Versus-Host Disease With Clofazimine
1997
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study
1996
Works of MR O’Donnell being referenced
Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients
2002
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission
1999
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission
2000
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies [published erratum appears in Blood 1987 Jun;69(6):1789]
1987
A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.
1987
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia
1987
Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors
1982
Coccidioidomycosis in bone marrow transplant recipients.
1993
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study [see comments]
1992
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission
1993
Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
1988
High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study.
1985
Prevention of refractoriness and HLA-alloimmunization using filtered blood products
1988
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission
1991
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission
1993
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase
1994
Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung
1986
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia
1987
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors
1995
Prevention of refractoriness and HLA-alloimmunization using filtered blood products
1988